New data suggests that retatrutide, a novel medication, could represent a significant advance in weight management. This drug combines the actions of a GLP-1 analog and a GIP analog, possibly offering a more impact than existing approaches . Study trials retatrutide dosing have revealed encouraging outcomes, including considerable declines in size